D. Lowry

发表

Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial.

T. Guarnieri, S. Nolan, S. Gottlieb, 1999, Journal of the American College of Cardiology.

Lipoprotein-cholesterol analysis during screening: accuracy and reliability.

D. Becker, D. Lowry, P. Bachorik, 1991, Annals of internal medicine.

Aspirin in Patients with Coronary Artery Disease: Is it Simply Irresistible?

D. Lowry, V. Serebruany, C. Davis, 2001, Journal of Thrombosis and Thrombolysis.

Moderate Alcohol Consumption is Associated with Decreased Platelet Activity in Patients Presenting with Acute Myocardial Infarction

C. O'connor, D. Lowry, P. Gurbel, 2000, Journal of Thrombosis and Thrombolysis.

Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study.

C. O'connor, S. Steinhubl, C. Hennekens, 2004, Archives of internal medicine.

Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study

D. Lowry, V. Serebruany, A. Malinin, 2006, Postgraduate Medical Journal.

Increased soluble platelet / endothelial cellular adhesion molecule‐1 and osteonectin levels in patients with severe congestive heart failure. Independence of disease etiology, and antecedent aspirin therapy

D. Atar, D. Lowry, P. Gurbel, 1999, European journal of heart failure.

Plasma thromboxane and prostacyclin are linear related and increased in patients presenting with acute myocardial infarction.

D. Lowry, P. Gurbel, V. Serebruany, 1999, Prostaglandins, leukotrienes, and essential fatty acids.

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial

C. O'connor, S. Steinhubl, D. Lowry, 2003 .

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.

C. O'connor, S. Steinhubl, D. Lowry, 2003, American heart journal.

Clinical Outcomes Comparing Eptifibatide and Abciximab in ST Elevation Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions

S. Gottlieb, D. Lowry, John Wang, 2006, Cardiology.

Antecedent Aspirin Therapy Inhibits Baseline Platelet Activity in Patients Presenting with Acute Myocardial Infarction

C. O'connor, R. Bahr, D. Lowry, 1998, Cardiology.

Depressed Plasma Platelet- Activating Factor Acetylhydrolasein Pat ients Presenting with Acute Myocardial Infarction

D. Lowry, P. Gurbel, V. Serebruany, 1998, Cardiology.

Effect of statins on platelet PAR-1 thrombin receptor in patients with the metabolic syndrome (from the PAR-1 inhibition by statins [PARIS] study).

C. Hennekens, D. Lowry, J. Tanguay, 2006, The American journal of cardiology.

Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel: Results From the Interaction Study

C. O'connor, S. Steinhubl, C. Hennekens, 2004 .

Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non‐compliance in patient enrolled in the JUMBO Trial

D. Lowry, V. Serebruany, A. Malinin, 2006, International journal of clinical practice.

Effects of Valsartan and Valeryl 4-Hydroxy Valsartan on Human Platelets: A Possible Additional Mechanism for Clinical Benefits

C. O'connor, C. Hennekens, S. Gottlieb, 2004, Journal of cardiovascular pharmacology.

Reevaluation of serum-plasma differences in total cholesterol concentration.

D. Lowry, P. Bachorik, D. Becker, 1990, JAMA.

Abstract 3803: Platelet Inhibition with Prasugrel (CS-747) versus Clopidogrel in Patients Undergoing Coronary Stenting: The Subset From the JUMBO Trial

D. Lowry, V. Serebruany, A. Malinin, 2006 .